Literature DB >> 6928644

Antibody-independent activation of the alternative complement pathway by measles virus-infected cells.

J G Sissons, M B Oldstone, R D Schreiber.   

Abstract

When HeLa cells acutely infected with measles virus were incubated in a mixture containing only the six proteins of the alternative pathway of complement activation (C3, factors B and D, beta 1H, C3b inactivator, and native properdin) without antibody, there was activation of the alternative pathway as shown by progressive uptake of 125I-labeled C3b onto the cell surface. This C3b uptake was blocked by EDTA and was not shown by uninfected cells. The rate of 125I-labeled C3 uptake by infected cells was the same in the absence and presence of properdin; however, when antiviral IgG was bound to the cell surface, the rate of C3 uptake was increased in the presence of properdin. Significant 125I-labeled C3 uptake was first detectable when cells were studied at 12 hr after infection, when cells expressed viral polypeptides on their surface. There was also progressive uptake of 125I-labeled C3 onto measles virus-infected cells incubated in human serum depleted of both IgG and C4. Hence, the human alternative pathway of complement activation can be initiated on the surface of measles virus-infected cells independent of IgG antibody. However, lysis of the infected cells only occurs when antiviral antibody is present.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6928644      PMCID: PMC348312          DOI: 10.1073/pnas.77.1.559

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Activation of the alternative complement pathway by lymphoblastoid cell lines derived from patients with Burkitt's lymphoma and infectious mononucleosis.

Authors:  D B Budzko; P J Lachmann; I McConnell
Journal:  Cell Immunol       Date:  1976-03-01       Impact factor: 4.868

2.  Protein iodination with solid state lactoperoxidase.

Authors:  G S David; R A Reisfeld
Journal:  Biochemistry       Date:  1974-02-26       Impact factor: 3.162

3.  The C3-activator system: an alternate pathway of complement activation.

Authors:  O Götze; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

Review 4.  Destruction of virus-infected cells by immunological mechanisms.

Authors:  D D Porter
Journal:  Annu Rev Microbiol       Date:  1971       Impact factor: 15.500

5.  Analysis of complement-dependent antibody-mediated lysis of target cells acutely infected with measles.

Authors:  J T Hicks; M J Klutch; P Albrecht; M M Frank
Journal:  J Immunol       Date:  1976-07       Impact factor: 5.422

6.  Binding of components of the properdin system to cultured human lymphoblastoid cells and B lymphocytes.

Authors:  A N Theofilopoulos; L H Perrin
Journal:  J Exp Med       Date:  1976-02-01       Impact factor: 14.307

7.  Mechanism of injury of virus-infected cells by antiviral antibody and complement: participation of IgG, F(ab')2, and the alternative complement pathway.

Authors:  L H Perrin; B S Joseph; N R Cooper; M B Oldstone
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

8.  The properdin system and immunity. VI. The inactivation of Newcastle disease virus by the properdin system.

Authors:  H S GINSBERG; L PILLEMER; R J WEDGWOOD
Journal:  J Exp Med       Date:  1956-11-01       Impact factor: 14.307

9.  Immunologic injury of cultured cells infected with measles virus. I. role of IfG antibody and the alternative complement pathway.

Authors:  B S Joseph; N R Cooper; M B Oldstone
Journal:  J Exp Med       Date:  1975-04-01       Impact factor: 14.307

10.  Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase.

Authors:  D T Fearon; K F Austen
Journal:  J Exp Med       Date:  1975-10-01       Impact factor: 14.307

View more
  33 in total

1.  Attachment of human polymorphonuclear leukocytes to herpes simplex virus-infected fibroblasts mediated by antibody-independent complement activation.

Authors:  J A van Strijp; K P van Kessel; L A Miltenburg; A C Fluit; J Verhoef
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

Review 2.  Molecular anatomy of viral persistence.

Authors:  M B Oldstone
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

3.  Analysis of the interactions between properdin, the third component of complement (C3), and its physiological activation products.

Authors:  T C Farries; P J Lachmann; R A Harrison
Journal:  Biochem J       Date:  1988-05-15       Impact factor: 3.857

4.  Vaccination to prevent persistent viral infection.

Authors:  M B Oldstone; A Tishon; M Eddleston; J C de la Torre; T McKee; J L Whitton
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

Review 5.  The alternative pathway of complement.

Authors:  M K Pangburn; H J Müller-Eberhard
Journal:  Springer Semin Immunopathol       Date:  1984

Review 6.  The role of antibody in the activation of the alternative complement pathway.

Authors:  W D Ratnoff; D T Fearon; K F Austen
Journal:  Springer Semin Immunopathol       Date:  1983

Review 7.  The complement system: its importance in the host response to viral infection.

Authors:  R L Hirsch
Journal:  Microbiol Rev       Date:  1982-03

8.  Activation of the alternative and classical complement pathways by Entamoeba histolytica.

Authors:  J Calderon; R D Schreiber
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

9.  Cell entry by measles virus: long hybrid receptors uncouple binding from membrane fusion.

Authors:  C J Buchholz; U Schneider; P Devaux; D Gerlier; R Cattaneo
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

10.  Sensitization of human tumor cells to homologous complement by vaccinia virus treatment.

Authors:  H Okada; N Wakamiya; N Okada; S Kato
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.